Adverse reactions or quality problems experienced with the use of this product can be reported to the FDA's MedWatch Adverse Event Reporting program online, by regular mail, or by fax (reporting forms can be downloaded here)
The Present and Future of Mitochondrial-Based Therapeutics for Eye Disease
Experimental literature describes BPC-157 as a relatively stable short peptide compared with many endogenous regulatory peptides
10.1016/S0091-3057(02)00724-4 Pharmacol
---------- 3000 mcg/mL Sterile Solution For animal use only
Reads with an average quality 2 mismatches in the bases for the remaining part of the primer were removed, and this resulted in a total of 3,332,352 tags, averaging 133,294 tags/sample with an average length of 481 bp